WuXi Biologics Ireland doubles turnover to €16.1 million in 2022
Company also trimmed its expenses during the year to €16.7 million, leaving it with a pre-tax loss of €6.9 million, down from €12.2 million the year before
WuXi Biologics Ireland, the Irish subsidiary of a Chinese biopharma and vaccine firm, increased its turnover from €8.4 million in 2021 to €16.1 million in 2022, new company accounts show.
The company also trimmed its expenses during the year to €16.7 million, leaving it with a pre-tax loss of €6.9 million, down from €12.2 million the year before. That left the company with accumulated profits of €12.3 million, €19.5 million.
The company had assets worth ...
